Dirk Forstmeyer

2.3k total citations
6 papers, 61 citations indexed

About

Dirk Forstmeyer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hepatology. According to data from OpenAlex, Dirk Forstmeyer has authored 6 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Hepatology. Recurrent topics in Dirk Forstmeyer's work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Virus-based gene therapy research (1 paper). Dirk Forstmeyer is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Virus-based gene therapy research (1 paper). Dirk Forstmeyer collaborates with scholars based in Germany. Dirk Forstmeyer's co-authors include Anja Mehnert, Oliver Wildner, Albert Heim, Verena Bröcker, Diana Richter, Jochen Ernst, Cornelia Henke‐Gendo, Kristina Geue, Thomas Kuhnt and Maren Knödler and has published in prestigious journals such as Journal of Medical Virology, Journal of Cancer Research and Clinical Oncology and CardioVascular and Interventional Radiology.

In The Last Decade

Dirk Forstmeyer

5 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Forstmeyer Germany 4 16 16 13 12 11 6 61
Ashwaghosha Parthasarathi India 6 15 0.9× 5 0.3× 6 0.5× 17 1.4× 7 0.6× 28 111
Kamal Patel United Kingdom 5 11 0.7× 13 0.8× 3 0.2× 17 1.4× 22 2.0× 16 80
Devleta Balić Bosnia and Herzegovina 7 26 1.6× 15 0.9× 10 0.8× 7 0.6× 14 128
Ahmed Nahari Saudi Arabia 7 12 0.8× 47 2.9× 10 0.8× 15 1.4× 13 145
Christine Peyron France 7 24 1.5× 19 1.2× 7 0.5× 3 0.3× 35 3.2× 22 119
Rose Stewart United Kingdom 7 15 0.9× 23 1.4× 1 0.1× 9 0.8× 27 2.5× 15 119
Ari Horton Australia 7 26 1.6× 38 2.4× 1 0.1× 6 0.5× 7 0.6× 26 137
Maxwell Akonde United States 7 12 0.8× 6 0.4× 10 0.8× 10 0.9× 20 95
Woldeteklehaymanot Kassahun Ethiopia 6 10 0.6× 2 0.1× 2 0.2× 7 0.6× 22 2.0× 12 94
Stephanie Meyers United States 5 8 0.5× 2 0.1× 5 0.4× 6 0.5× 3 0.3× 7 52

Countries citing papers authored by Dirk Forstmeyer

Since Specialization
Citations

This map shows the geographic impact of Dirk Forstmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Forstmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Forstmeyer more than expected).

Fields of papers citing papers by Dirk Forstmeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Forstmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Forstmeyer. The network helps show where Dirk Forstmeyer may publish in the future.

Co-authorship network of co-authors of Dirk Forstmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Forstmeyer. A scholar is included among the top collaborators of Dirk Forstmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Forstmeyer. Dirk Forstmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Ebel, Sebastian, Florian Lordick, Dirk Forstmeyer, et al.. (2024). The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 150(2). 81–81. 1 indexed citations
2.
Moche, Michael, Sebastian Ebel, Timm Denecke, et al.. (2021). Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers. CardioVascular and Interventional Radiology. 45(2). 218–222. 3 indexed citations
3.
Wuerstlein, Rachel, Nadia Harbeck, Eva‐Maria Grischke, et al.. (2020). Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients. Breast Care. 16(1). 50–58.
4.
Richter, Diana, Anja Mehnert, Dirk Forstmeyer, Jochen Ernst, & Kristina Geue. (2019). Health Literacy in Adolescent and Young Adult Cancer Patients and Its Association with Health Outcomes. Journal of Adolescent and Young Adult Oncology. 8(4). 451–457. 20 indexed citations
5.
Moritz, F., Thomas Kuhnt, Maryam Yahiaoui‐Doktor, et al.. (2019). The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study. Journal of Geriatric Oncology. 10(6). 937–943. 18 indexed citations
6.
Forstmeyer, Dirk, Cornelia Henke‐Gendo, Verena Bröcker, Oliver Wildner, & Albert Heim. (2007). Quantitative temporal and spatial distribution of adenovirus type 2 correlates with disease manifestations and organ failure during disseminated infection. Journal of Medical Virology. 80(2). 294–297. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026